1492 Capital Management LLC Intellia Therapeutics, Inc. Transaction History

1492 Capital Management LLC

  • $184 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$34.58 - $46.03 $172 - $230
-5 Reduced 0.04%
11,164 $455,000
Q1 2023

May 12, 2023
SELL
$33.3 - $44.82 $133 - $179
-4 Reduced 0.04%
11,169 $416,000
Q3 2022

Nov 10, 2022
BUY
$53.92 - $71.7 $11,700 - $15,558
217 Added 1.98%
11,173 $625,000
Q2 2022

Aug 10, 2022
BUY
$38.49 - $76.21 $421,696 - $834,956
10,956 New
10,956 $567,000

Others Institutions Holding NTLA

# of Institutions
316
Shares Held
91.7M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $722M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track 1492 Capital Management LLC Portfolio

Follow 1492 Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1492 Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on 1492 Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email